NasdaqIndustrialsWholesale-Durable Goods, NECBERKELEY HEIGHTS, NJ

Bio Green Med Solution, Inc. BGMS

Ask your AI

Estimated market cap $4.24M6.62M shares, shares as of Nov 11, 2026CIK 1130166

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

1.0% of shares · 1 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Bio Green Med Solution, Inc.'s latest quarterly report, compared with the one before.

Filed Nov 12, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Bio Green Med Solution, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Nov 5, 2025. Insiders have two business days to file.

Recent insider trades

Kim Choy Yap 10% owner	Nov 5, 2025 Form 4 ↗	Sale	−$48.5K 28,540 sh @ $1.70	-72.5%
Kim Choy Yap 10% owner	Oct 30, 2025 Form 4 ↗	Sale	−$203.2K 112,260 sh @ $1.81	-75.8%
Khai Loon Kua 10% owner	Oct 30, 2025 Form 4 ↗	Sale	−$436.5K 242,477 sh @ $1.80	-75.8%
Yee Lung Ong 10% owner	Oct 30, 2025 Form 4 ↗	Sale	−$447.9K 248,814 sh @ $1.80	-75.8%
Kim Choy Yap 10% owner	Oct 29, 2025 Form 4 ↗	Sale	−$202.7K 110,749 sh @ $1.83	-74.2%

All BGMS insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

66,965 shares

8 funds report BGMS. Values checked against market prices.

Funds own 1.5% of shares (Q2 2026)

7 funds hold the stock.

Q3 2026: 1.0% · 5,560 of ~8,900 funds reported so far

Q2 2025<0.1%
Q3 2025<0.1%
Q4 20251.6%
Q1 20262.1%
Q2 20261.5%
Q3 2026 (so far)1.0%

Q3 2026. 4 new, 1 added to, 3 trimmed, 3 exited since Q2 2026.

Top 13F holders
#
1	Vanguard Fiduciary Trust Co 13F ↗	55,704	$49.1K	New
2	Jane Street Group, LLC 13F ↗	10,474	$9,239	-35.7%
3	SBI Securities Co., Ltd. 13F ↗	730	$644	+4.1%
4	UBS Group AG 13F ↗	44	$39	-99.0%
5	Root Financial Partners, LLC 13F ↗	7	$6	New
6	Barclays plc 13F ↗	4	$4	New
7	Archer Investment Corp 13F ↗	1	$1	-50.0%
8	Citigroup Inc 13F ↗	1	$1	New

Download CSV Every fund that holds BGMS, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Bio Green Med Solution, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Bio Green Med Solution, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report, adjusted for splits

Funds holding the stock by quarter

Q2 2025	1	—	5	$25
Q3 2025	6	+5	1,117	$5,522
Q4 2025	9	+3	79,038	$117.0K
Q1 2026	9	0	118,543	$118.5K
Q2 2026	7	-2	102,289	$93.1K
Q3 2026	8	+1	66,965	$59.1K

Each point is a quarter-end, from Q2 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (23254L876). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits (1-for-15 on Jul 7, 2025): reports from before a split are multiplied by its ratio, so every quarter is on the share count of Q3 2026.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes5 in 12 mo 8-K events3 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive pay3 fiscal years Wikipedia attentionLatest Nov 13 SEC enforcementNone on record Pending deal1 deal filed lately IPO history8 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Bio Green Med Solution, Inc.
Address: 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ 07922
Phone: 908-517-7330
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: BGMS (Nasdaq), BGMSP (OTC)
Former names: Cyclacel Pharmaceuticals, Inc. (until 2025); XCYTE THERAPIES INC (until 2006)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.6403−$0.07 (−9.83%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.6403 · High $1.00Nov 13, 2026

Aug 13, 2026Low $0.6403 · High $1.05Nov 13, 2026

Nov 13, 2025Low $0.601 · High $1.82Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.